Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis

Background and Aims Rectal indomethacin is a popular chemopreventive agent to help prevent post-ERCP pancreatitis (PEP). Previous meta-analyses have shown an overall protective effect for PEP in average-risk and high-risk patients. However, these meta-analyses are limited by a small number of studie...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gastrointestinal endoscopy 2017-01, Vol.85 (1), p.67-75
Hauptverfasser:	Inamdar, Sumant, MBBS, MPH, Han, Dennis, MD, Passi, Monica, MD, Sejpal, Divyesh V., MD, Trindade, Arvind J., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Rectal Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Cholangiopancreatography, Endoscopic Retrograde - adverse effects Gastroenterology and Hepatology Humans Indomethacin - administration & dosage Pancreatitis - etiology Pancreatitis - prevention & control Randomized Controlled Trials as Topic Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!